Back to Journals » Therapeutics and Clinical Risk Management » Volume 16

Comparative Treatment Patterns and Outcomes of Fulvestrant versus Everolimus Plus Exemestane for Postmenopausal Metastatic Breast Cancer Resistant to Aromatase Inhibitors in Real-World Experience

Total article views   Abstract views HTML views PDF downloads Totals
1,948 Dovepress* 1,724 161+ 452 1,885
PubMed Central* 0 63 23 63
Totals 1,724 224 475 1,948
*Since 30 June 2020
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed Central and Google Scholar